P3205 - Assessing the Impact of Mainstream Media Misinformation on Intent to Undergo Colorectal Cancer (CRC) Screening Among Marginalized Communities: Results From an Online Randomized Controlled Trial (RCT)
Kushagra Mathur, MD, Eden Sharabi, MD, MS, So Yung Choi, MS, Barbara Hollander, MD, Brennan Spiegel, MD, MSHS, Christopher V. Almario, MD, MSHPM Cedars-Sinai Medical Center, Los Angeles, CA
Introduction: While the NordICC trial showed that colonoscopy reduced CRC incidence (31%) and mortality (50%) in per-protocol analysis, many media outlets focused on the intention-to-screen findings (i.e., no change in mortality) with headlines questioning the effectiveness of colonoscopy. We hypothesized that misleading news reports on the NordICC trial may have disproportionately affected perceptions of CRC screening in marginalized communities. To test our hypothesis, we performed a secondary analysis of data from an online RCT assessing the impact of two media articles (one rated high- and one low-quality in terms of scientific accuracy) on intention to undergo colonoscopic CRC screening.
Methods: We recruited a representative nationwide sample of unscreened Americans aged 45-75y at average risk for CRC to complete the survey. Participants were randomized 1:1 to review a high- or low-quality media article on the NordICC trial as determined by 19 gastroenterologists using the Quality Index for Health-Related Media Reports scale. Individuals answered questions on their intent to undergo colonoscopic CRC screening before and after reading the article. The primary outcome was a negative change in intent to undergo colonoscopy (Figure). To assess whether the low-quality article differentially affected screening perceptions in certain groups, we conducted regression models with interaction terms between the assigned article and age, sex, race/ethnicity, education, and income.
Results: Of the 2013 individuals surveyed, 1531 (76.1%) stated they planned to do a colonoscopy or were undecided before reading their assigned article. After reading the article, 10.6% of people no longer intended to do a colonoscopy; no difference was seen between the high- and low-quality articles (adjusted p=0.20). The Table shows data from the regression models with interaction terms between the assigned article and age, sex, race/ethnicity, education, and income. The low-quality article did not disproportionally affect screening perceptions across the various sociodemographic groups (all adjusted p >0.05).
Discussion: We found that a low-quality article on the NordICC trial did not differentially impact people’s attitudes towards colonoscopic CRC screening in traditionally marginalized groups. While this is reassuring, coverage of the NordICC trial still led ~10% of people to change their mind on colonoscopy, underscoring the importance of responsible reporting of clinical research by the media.
Figure: FIGURE. Definition for a negative change in people’s plans to be screened.
Disclosures:
Kushagra Mathur indicated no relevant financial relationships.
Eden Sharabi indicated no relevant financial relationships.
So Yung Choi indicated no relevant financial relationships.
Barbara Hollander indicated no relevant financial relationships.
Christopher Almario: 3M – Stock-publicly held company(excluding mutual/index funds). Doximity – Stock-publicly held company(excluding mutual/index funds). Exact Sciences – Advisory Committee/Board Member. Gilead Sciences – Stock-publicly held company(excluding mutual/index funds). Madrigal Pharmaceuticals – Stock-publicly held company(excluding mutual/index funds). My Total Health – Stock Options. Owlstone Medical – Consultant, Stock Options. Sanofi – Advisory Committee/Board Member.
Kushagra Mathur, MD, Eden Sharabi, MD, MS, So Yung Choi, MS, Barbara Hollander, MD, Brennan Spiegel, MD, MSHS, Christopher V. Almario, MD, MSHPM. P3205 - Assessing the Impact of Mainstream Media Misinformation on Intent to Undergo Colorectal Cancer (CRC) Screening Among Marginalized Communities: Results From an Online Randomized Controlled Trial (RCT), ACG 2023 Annual Scientific Meeting Abstracts. Vancouver, BC, Canada: American College of Gastroenterology.